Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VyraMed
- Development stage
- Unknown
- Lead developer
- FetTech
- Administration
- Topical
01
Overview
VyraMed is a broad-spectrum antiviral product developed by FetTech, utilizing their proprietary Multi-Tissue Platform (MTP®). Originally derived from extracellular matrix (ECM) technology for regenerative medicine, MTP was found to possess potent antiviral properties specifically against enveloped viruses. It works by reducing viral infectivity (up to 99.9% in NIAID-sponsored studies) and preventing the spread of viruses within human tissue. The platform is naturally derived from multiple tissue sources and is effective against a wide range of pathogens, including herpes simplex virus (HSV), varicella zoster virus (VZV), coronaviruses, HIV, hepatitis, and Ebola. VyraMed is available in multiple formulations, such as powder and gel, and is part of a family of FDA-cleared ECM products that includes XCelliStem for wound care.
- Brand names
- VyraMed
- Other names
- MTP Anti-Viral
Beyond the preview
Go deeper on VyraMed.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VyraMed.